Conjoint Statement of the SNM, ACNM, and ABNM on credentialing and delineation of privileges for therapeutic procedures using radiopharmaceuticals.

The training requirements for the supervision and administration of therapeutic procedures using radiopharmaceuticals are not defined uniformly in the Accreditation Council of Graduate Medical Education (ACGME) program requirements for different specialties. The training requirements of the Nuclear Regulatory Commission (NRC) are intended for the safe handling of radioisotopes, which is only a prerequisite to the safe practice of medicine. The purpose of this document is to recommend the minimum training requirements for therapeutic procedures using radiopharmaceuticals. These requirements should be uniform across ACGME specialty training requirements. This training must include independently evaluating and treating, under supervision, a minimum of 10 cases of radioiodine therapy for hyperthyroidism, a minimum of 5 cases of radioiodine therapy for thyroid carcinoma, and a minimum of 3 cases of parenteral radionuclide therapy. Less training and experience is inadequate to ensure the safety, appropriateness, and effectiveness of radionuclide therapy.